MedTrace Logo

ClariCore System Used in Transperineal Prostate Biopsy

NCT03734575 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-07-11

No results posted yet for this study

Summary

The overall objective of this study is to acquire ultrasound images, spectral data and prostate tissue biopsy cores using the ClariCore System via a transperineal approach.

Conditions

Interventions

DEVICE

ClariCore System

The user will perform a standard trans-perineal biopsy and collect a number of biopsy cores as per standard practice.

Sponsors & Collaborators

  • Precision Biopsy, Inc.

    lead INDUSTRY

Principal Investigators

  • James Wysock, MD · NYU Langone Urology Associates

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-10
Primary Completion
2019-07-09
Completion
2019-07-09
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03734575 on ClinicalTrials.gov